InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
6
T+90 hit rate
100%
T+90 mean return
+28.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Kuch John J, Chief Financial Officer. Insider active across 1 company, notably Xencor Inc. Cumulatively, 10 disclosures have been published. Split: 0 buy · 6 sells. Total volume traded: €261k. Activity tracked since 29 June 2021. The latest transaction was disclosed on 11 March 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
849 shares@ US$23.50184.0% of flowCommon StockSEC:0001127602-24-009728:0
4,474 shares@ US$23.42921.1% of flowCommon StockSEC:0001127602-24-009002:0
711 shares@ US$29.87934.4% of flowCommon StockSEC:0001127602-23-009963:0
2,774 shares@ US$31.415917.9% of flowCommon StockSEC:0001127602-23-009514:0
12,005 shares0Common StockSEC:0001127602-23-009199:0
690 shares@ US$28.93450.0017% mcap7.6% of flowCommon StockSEC:0001415889-22-002840:0
971 shares@ US$29.86010.0024% mcap10.8% of flowCommon StockSEC:0001415889-22-002665:0
10,585 shares@ US$11.050.0089% mcap40.8% of flowCommon StockSEC:0001415889-21-003351:0
10,585 shares@ US$11.0521.5% of flowCommon StockSEC:0001415889-21-003351
16,951 sharesCommon StockSEC:0001209191-16-091369:0
10 of 10 declarations
About Kuch John J
John J. Kuch is Senior Vice President and Chief Financial Officer at Xencor Inc. He is responsible for the company's financial management, including financial planning and analysis. With a strong background in the biopharmaceutical sector, he plays a key role in Xencor's financial strategy, which develops innovative treatments for autoimmune diseases.
